Zobrazeno 1 - 10
of 628
pro vyhledávání: '"Zois, CE"'
Autor:
Tan KL; Tumour Pathology Laboratory, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK; Faculty of Medicine and Health Sciences, Universiti Sains Islam Malaysia (USIM), Persiaran Ilmu, Putra Nilai, 71800 Nilai, Negeri Sembilan, Malaysia. Electronic address: kaliong_tan@usim.edu.my., Haider S; Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK; Computational Biology and Integrative Genomics, Department of Oncology, Old Road Campus Research Building, Roosevelt Drive Oxford, University of Oxford, UK; The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK. Electronic address: Syed.Haider@icr.ac.uk., Zois CE; Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK., Hu J; Tumour Pathology Laboratory, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK., Turley H; Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK., Leek R; Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK., Buffa F; Computational Biology and Integrative Genomics, Department of Oncology, Old Road Campus Research Building, Roosevelt Drive Oxford, University of Oxford, UK., Acuto O; Laboratory of T-cell signalling, Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK., Harris AL; Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK., Pezzella F; Tumour Pathology Laboratory, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK. Electronic address: francesco.pezzella@ndcls.ox.ac.uk.
Publikováno v:
Translational oncology [Transl Oncol] 2024 Nov; Vol. 49, pp. 102106. Date of Electronic Publication: 2024 Aug 24.
Autor:
Yalaz C; Molecular Oncology Laboratories, Department of Medical Oncology, John Radcliffe Hospital, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, UK. cerenyalaz@gmail.com., Bridges E; Molecular Oncology Laboratories, Department of Medical Oncology, John Radcliffe Hospital, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, UK., Alham NK; Department of Engineering Science, Institute of Biomedical Engineering (IBME), University of Oxford, Old Road Campus Research Building, Oxford, OX3 7DQ, UK., Zois CE; Molecular Oncology Laboratories, Department of Medical Oncology, John Radcliffe Hospital, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, UK., Chen J; Department of Oncology, University of Oxford, Old Road Campus Research Building, Oxford, OX3 7DQ, UK., Bensaad K; Molecular Oncology Laboratories, Department of Medical Oncology, John Radcliffe Hospital, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, UK., Miar A; Department of Oncology, University of Oxford, Old Road Campus Research Building, Oxford, OX3 7DQ, UK., Pires E; Department of Chemistry, University of Oxford, Mansfield Road, Oxford, OX1 3TA, UK., Muschel RJ; Department of Oncology, University of Oxford, Old Road Campus Research Building, Oxford, OX3 7DQ, UK., McCullagh JSO; Department of Chemistry, University of Oxford, Mansfield Road, Oxford, OX1 3TA, UK., Harris AL; Molecular Oncology Laboratories, Department of Medical Oncology, John Radcliffe Hospital, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, UK.
Publikováno v:
Cancer & metabolism [Cancer Metab] 2024 Feb 13; Vol. 12 (1), pp. 5. Date of Electronic Publication: 2024 Feb 13.
Autor:
de Heer EC; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, PO Box 30.001, Groningen, 9700 RB, The Netherlands., Zois CE; Department of Oncology, Weatherall Institute of Molecular Medicine, Hypoxia and Angiogenesis Group, Cancer Research UK Molecular Oncology Laboratories, University of Oxford, Oxford, OX3 9DS, UK. christos.zois@oncology.ox.ac.uk.; Department of Radiotherapy and Oncology, School of Health, Democritus University of Thrace, Alexandroupolis, Greece. christos.zois@oncology.ox.ac.uk.; Department of Oncology, MRC Weatherall Institute of Molecular Medicine, Molecular Oncology Laboratories, John Radclife Hospital, Oxford University, Oxford, OX3 9DS, UK. christos.zois@oncology.ox.ac.uk., Bridges E; Department of Oncology, Weatherall Institute of Molecular Medicine, Hypoxia and Angiogenesis Group, Cancer Research UK Molecular Oncology Laboratories, University of Oxford, Oxford, OX3 9DS, UK., van der Vegt B; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Sheldon H; Department of Oncology, Weatherall Institute of Molecular Medicine, Hypoxia and Angiogenesis Group, Cancer Research UK Molecular Oncology Laboratories, University of Oxford, Oxford, OX3 9DS, UK., Veldman WA; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, PO Box 30.001, Groningen, 9700 RB, The Netherlands., Zwager MC; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., van der Sluis T; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Haider S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Morita T; Tokushima University Graduate School, 3-18-15, Kuramoto-Cho, Tokushima, 770-8504, Japan., Baba O; Tokushima University Graduate School, 3-18-15, Kuramoto-Cho, Tokushima, 770-8504, Japan., Schröder CP; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, PO Box 30.001, Groningen, 9700 RB, The Netherlands.; Department of Medical Oncology, Antoni Van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, The Netherlands., de Jong S; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, PO Box 30.001, Groningen, 9700 RB, The Netherlands., Harris AL; Department of Oncology, Weatherall Institute of Molecular Medicine, Hypoxia and Angiogenesis Group, Cancer Research UK Molecular Oncology Laboratories, University of Oxford, Oxford, OX3 9DS, UK., Jalving M; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, PO Box 30.001, Groningen, 9700 RB, The Netherlands. m.jalving@umcg.nl.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Aug 28; Vol. 42 (1), pp. 220. Date of Electronic Publication: 2023 Aug 28.
Autor:
Zois, CE, Hendriks, AM, Haider, S, Pires, E, Bridges, E, Kalamida, D, Voukantsis, D, Lagerholm, BC, Fehrmann, RSN, den Dunnen, WFA, Tarasov, AI, Baba, O, Morris, J, Buffa, FM, McCullagh, JSO, Jalving, M, Harris, AL
Publikováno v:
Cell death & disease, 13(6):573. Nature Publishing Group
Channelling of glucose via glycogen, known as the glycogen shunt, may play an important role in the metabolism of brain tumours, especially in hypoxic conditions. We aimed to dissect the role of glycogen degradation in glioblastoma (GBM) response to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a06de15fcf3391c2662033fa4d150bd3
https://ora.ox.ac.uk/objects/uuid:5555c4fb-2bc5-42e8-a03b-e5aaa7863be8
https://ora.ox.ac.uk/objects/uuid:5555c4fb-2bc5-42e8-a03b-e5aaa7863be8
Autor:
de Heer EC; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, PO Box 30.001, 9700 RB, Groningen, The Netherlands., Zois CE; Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, Hypoxia and Angiogenesis Group, Cancer Research UK Molecular Oncology Laboratories, Oxford, OX3 9DS, UK. christos.zois@oncology.ox.ac.uk.; Department of Radiotherapy and Oncology, School of Health, Democritus University of Thrace, Alexandroupolis, Greece. christos.zois@oncology.ox.ac.uk.; Department of Oncology, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Molecular Oncology Laboratories, Oxford University, Oxford, OX3 9DS, UK. christos.zois@oncology.ox.ac.uk., Bridges E; Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, Hypoxia and Angiogenesis Group, Cancer Research UK Molecular Oncology Laboratories, Oxford, OX3 9DS, UK., van der Vegt B; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Sheldon H; Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, Hypoxia and Angiogenesis Group, Cancer Research UK Molecular Oncology Laboratories, Oxford, OX3 9DS, UK., Veldman WA; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, PO Box 30.001, 9700 RB, Groningen, The Netherlands., Zwager MC; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., van der Sluis T; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Haider S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Morita T; Tokushima University Graduate School, 3-18-15, Kuramoto-Cho, Tokushima, 770-8504, Japan., Baba O; Tokushima University Graduate School, 3-18-15, Kuramoto-Cho, Tokushima, 770-8504, Japan., Schröder CP; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, PO Box 30.001, 9700 RB, Groningen, The Netherlands.; Department of Medical Oncology, Antoni Van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, the Netherlands., de Jong S; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, PO Box 30.001, 9700 RB, Groningen, The Netherlands., Harris AL; Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, Hypoxia and Angiogenesis Group, Cancer Research UK Molecular Oncology Laboratories, Oxford, OX3 9DS, UK., Jalving M; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, PO Box 30.001, 9700 RB, Groningen, The Netherlands. m.jalving@umcg.nl.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Jun 06; Vol. 42 (1), pp. 143. Date of Electronic Publication: 2023 Jun 06.
Publikováno v:
Web of Science
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::df4d93b0446a87bb81f87148988903ab
https://doi.org/10.1007/s00259-017-3822-1
https://doi.org/10.1007/s00259-017-3822-1
Autor:
Lamprou I; Department of Radiotherapy/Oncology, Democritus University of Thrace, PO BOX 12, 68100, Alexandroupolis, Greece., Tsolou A; Department of Radiotherapy/Oncology, Democritus University of Thrace, PO BOX 12, 68100, Alexandroupolis, Greece., Kakouratos C; Department of Radiotherapy/Oncology, Democritus University of Thrace, PO BOX 12, 68100, Alexandroupolis, Greece., Mitrakas AG; Department of Radiotherapy/Oncology, Democritus University of Thrace, PO BOX 12, 68100, Alexandroupolis, Greece., Xanthopoulou ET; Department of Radiotherapy/Oncology, Democritus University of Thrace, PO BOX 12, 68100, Alexandroupolis, Greece., Kassela K; Laboratory of Biology, Democritus University of Thrace, 68100, Alexandroupolis, Greece., Karakasiliotis I; Laboratory of Biology, Democritus University of Thrace, 68100, Alexandroupolis, Greece., Zois CE; Department of Radiotherapy/Oncology, Democritus University of Thrace, PO BOX 12, 68100, Alexandroupolis, Greece., Giatromanolaki A; Department of Pathology, Democritus University of Thrace, 68100, Alexandroupolis, Greece., Koukourakis MI; Department of Radiotherapy/Oncology, Democritus University of Thrace, PO BOX 12, 68100, Alexandroupolis, Greece. targ@her.forthnet.gr.
Publikováno v:
Medical oncology (Northwood, London, England) [Med Oncol] 2021 Aug 19; Vol. 38 (10), pp. 116. Date of Electronic Publication: 2021 Aug 19.
Autor:
Zois CE; Molecular Oncology Laboratories, Department of Oncology, Oxford University, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK. christos.zois@oncology.ox.ac.uk., Hendriks AM; Molecular Oncology Laboratories, Department of Oncology, Oxford University, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK.; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Haider S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Pires E; Department of Chemistry, University of Oxford, Oxford, UK., Bridges E; Molecular Oncology Laboratories, Department of Oncology, Oxford University, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK., Kalamida D; Department of Oncology, Democritus University of Thrace, Alexandroupolis, Greece., Voukantsis D; The Bioinformatics Hub, Department of Oncology, University of Oxford, Oxford, UK., Lagerholm BC; Wolfson Imaging Centre Oxford, MRC Weatherall Institute of Molecular Medicine, Oxford, UK., Fehrmann RSN; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., den Dunnen WFA; Department of Pathology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Tarasov AI; Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford, UK.; School of Biomedical Sciences, Ulster University, Coleraine, Northern Ireland, UK., Baba O; Tokushima University Graduate School, Tokushima, Japan., Morris J; Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK., Buffa FM; Department of Oncology, University of Oxford, Churchill Hospital, Oxford, UK., McCullagh JSO; Department of Chemistry, University of Oxford, Oxford, UK., Jalving M; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Harris AL; Molecular Oncology Laboratories, Department of Oncology, Oxford University, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK. adrian.harris@oncology.ox.ac.uk.
Publikováno v:
Cell death & disease [Cell Death Dis] 2022 Jun 28; Vol. 13 (6), pp. 573. Date of Electronic Publication: 2022 Jun 28.
Autor:
Celora GL; Mathematical Institute, University of Oxford, Oxford, United Kingdom. Electronic address: celora@maths.ox.ac.uk., Byrne HM; Mathematical Institute, University of Oxford, Oxford, United Kingdom., Zois CE; Molecular Oncology Laboratories, Department of Oncology, Oxford University, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom; Department of Radiotherapy and Oncology, School of Health, Democritus University of Thrace, 68100 Alexandroupolis, Greece., Kevrekidis PG; Department of Mathematics & Statistics, University of Massachusetts, Amherst 01003, USA.
Publikováno v:
Journal of theoretical biology [J Theor Biol] 2021 Oct 21; Vol. 527, pp. 110792. Date of Electronic Publication: 2021 Jun 01.
Autor:
Lim B; Department of Engineering Science, University of Oxford, Parks Road, Oxford, OX1 3PJ, UK.; Department of Engineering Science, Institute of Biomedical Engineering, University of Oxford, Oxford, OX3 7DQ, UK., Ratcliff J; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, OX1 3SY, UK., Nawrot DA; Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, UK., Yu Y; Department of Engineering Science, University of Oxford, Parks Road, Oxford, OX1 3PJ, UK.; Department of Engineering Science, Institute of Biomedical Engineering, University of Oxford, Oxford, OX3 7DQ, UK., Sanghani HR; Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, UK., Hsu CC; Department of Engineering Science, University of Oxford, Parks Road, Oxford, OX1 3PJ, UK.; Department of Engineering Science, Institute of Biomedical Engineering, University of Oxford, Oxford, OX3 7DQ, UK., Peto L; Department of Microbiology, Oxford University NHS Foundation Trust, Oxford, UK., Evans S; Department of Microbiology, Oxford University NHS Foundation Trust, Oxford, UK., Hodgson SH; Department of Microbiology, Oxford University NHS Foundation Trust, Oxford, UK.; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Skeva A; Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupoli, Greece., Adam M; Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupoli, Greece., Panopoulou M; Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupoli, Greece., Zois CE; Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupoli, Greece., Poncin K; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK., Vasudevan SR; Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, UK., Dai S; Department of Engineering Science, University of Oxford, Parks Road, Oxford, OX1 3PJ, UK.; Department of Engineering Science, Institute of Biomedical Engineering, University of Oxford, Oxford, OX3 7DQ, UK., Ren S; Department of Engineering Science, University of Oxford, Parks Road, Oxford, OX1 3PJ, UK.; Department of Engineering Science, Institute of Biomedical Engineering, University of Oxford, Oxford, OX3 7DQ, UK., Chang H; Oxford Suzhou Centre for Advanced Research (OSCAR), University of Oxford, Suzhou, China., Cui Z; Department of Engineering Science, University of Oxford, Parks Road, Oxford, OX1 3PJ, UK.; Department of Engineering Science, Institute of Biomedical Engineering, University of Oxford, Oxford, OX3 7DQ, UK.; Oxford Suzhou Centre for Advanced Research (OSCAR), University of Oxford, Suzhou, China., Simmonds P; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, OX1 3SY, UK., Huang WE; Department of Engineering Science, University of Oxford, Parks Road, Oxford, OX1 3PJ, UK. wei.huang@eng.ox.ac.uk.; Oxford Suzhou Centre for Advanced Research (OSCAR), University of Oxford, Suzhou, China. wei.huang@eng.ox.ac.uk., Andersson MI; Department of Microbiology, Oxford University NHS Foundation Trust, Oxford, UK. Monique.Andersson@ndcls.ox.ac.uk.; Nuffield Division of Clinical Laboratory Science, Radcliffe Department of Medicine, University of Oxford, Oxford, UK. Monique.Andersson@ndcls.ox.ac.uk.
Publikováno v:
Scientific reports [Sci Rep] 2021 Aug 10; Vol. 11 (1), pp. 16193. Date of Electronic Publication: 2021 Aug 10.